Exhibit 10.62 CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO REGULATION 240.25B-2B OF THE SECURITIES EXCHANGE ACT OF 1934. [*] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST AND IS FILED...Collaboration and License Agreement • April 6th, 1999 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledApril 6th, 1999 Company Industry